10.07.2015 Views

BNF for Children 2011-2012

BNF for Children 2011-2012

BNF for Children 2011-2012

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

<strong>BNF</strong>C <strong>2011</strong>–<strong>2012</strong> 7.4 Drugs <strong>for</strong> genito-urinary disorders 409women accordingly]. There is no need to increase thedose <strong>for</strong> emergency contraception if the patient is takingantibacterials that are not enzyme inducers.LEVONORGESTRELCautions see notes above; past ectopic pregnancy;severe malabsorption syndromes; active trophoblasticdisease (until return to normal of urine- and plasmagonadotrophinconcentration)—seek specialistadvice; interactions: see notes above and Appendix 1(progestogens)Contra-indications acute porphyria (section 9.8.2)Pregnancy not known to be harmfulBreast-feeding progestogen-only contraceptives donot affect lactationSide-effects menstrual irregularities (see also notesabove), nausea, low abdominal pain, fatigue, headache,dizziness, breast tenderness, vomitingLicensed use consult product literatureIndication and doseEmergency contraception. By mouth1.5 mg as a single dose as soon as possible aftercoitus (preferably within 12 hours but no later thanafter 72 hours)1Levonelle c One Step (Bayer Schering)Tablets, levonorgestrel 1.5 mg, net price 1-tab pack =£13.831. Can be sold to women over 16 years; when supplyingemergency contraception to the public, pharmacists shouldrefer to guidance issued by the Royal PharmaceuticalSocietyLevonelle c 1500 (Bayer Schering) ATablets, levonorgestrel 1.5 mg, net price 1-tab pack =£5.20ULIPRISTAL ACETATECautions see notes above; uncontrolled severeasthma; effectiveness of combined hormonal andprogestogen-only contraceptives may be reduced—additional precautions (barrier methods) required;repeated use within a menstrual cycle; interactions:see notes above and Appendix 1 (ulipristal)Hepatic impairment manufacturer advises avoid insevere impairment—no in<strong>for</strong>mation availablePregnancy limited in<strong>for</strong>mation availableBreast-feeding manufacturer advises avoid <strong>for</strong> atleast 36 hours—no in<strong>for</strong>mation availableSide-effects gastro-intestinal disturbances (includingnausea, vomiting, diarrhoea, and abdominal pain);dizziness, fatigue, headache; menstrual irregularities(see notes above); back pain, muscle spasms; lesscommonly tremor, hot flushes, uterine spasm, breasttenderness, dry mouth, blurred vision, pruritus, andrashIndication and doseEmergency contraception. By mouth30 mg as a single dose as soon as possible aftercoitus, but no later than after 120 hoursellaOne c (HRA Pharma) TATablets, ulipristal acetate 30 mg, net price 1-tab pack= £16.95Intra-uterine deviceInsertion of an intra-uterine device is more effectivethan oral levonorgestrel <strong>for</strong> emergency contraception,see also notes above. A copper intra-uterine contraceptivedevice (section 7.3.4) can be inserted up to120 hours (5 days) after unprotected intercourse; sexuallytransmitted infections should be tested <strong>for</strong> andinsertion of the device should usually be covered byantibacterial prophylaxis (e.g. azithromycin 1 g as asingle dose). If intercourse has occurred more than 5days previously, the device can still be inserted up to 5days after the earliest likely calculated ovulation (i.e.within the minimum period be<strong>for</strong>e implantation),regardless of the number of episodes of unprotectedintercourse earlier in the cycle.7.4 Drugs <strong>for</strong> genito-urinarydisorders7.4.1 Drugs <strong>for</strong> urinary retention7.4.2 Drugs <strong>for</strong> urinary frequency, enuresis,and incontinence7.4.3 Drugs used in urological pain7.4.4 Bladder instillations and urologicalsurgery7.4.5 Drugs <strong>for</strong> erectile dysfunctionFor drugs used in the treatment of urinary-tract infectionssee section 5.1.13.7.4.1 Drugs <strong>for</strong> urinaryretentionAcute retention is painful and is treated by catheterisation.Chronic retention is painless and often long-standing.Clean intermittent catheterisation may be considered.After the cause has been established and treated, drugsmay be required to increase detrusor muscle tone.Alpha-blockers such as doxazosin and tamsulosin canbe used in some cases of dysfunctional voiding.Alpha-blockersThe selective alpha-blockers doxazosin and tamsulosincan be used to improve bladder emptying in childrenwith dysfunctional voiding where the post-void residualurine volume is significant; treatment should be underspecialist advice only. Alpha-blockers can reduce bloodpressure rapidly after the first dose and should beintroduced with caution.DOXAZOSINCautions see under Doxazosin (section 2.5.4)Contra-indications see under Doxazosin (section2.5.4)Hepatic impairment see under Doxazosin (section2.5.4)Pregnancy see under Doxazosin (section 2.5.4)7 Obstetrics, gynaecology, and urinary-tract disorders

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!